Precise Sarcoma Therapy: Dresden Research Team Develops Image-Guided Molecular Treatment

Дата публикации: 16-07-2026 08:08:00

One of the challenges of cancer therapy is the most complete possible removal of even the smallest residual tumor cells during treatment. For the treatment of sarcomas, the research group led by Prof. Oliver Bruns at the National Center for Tumor Diseases (NCT/UCC) Dresden is pursuing a novel strategy: using a specialized contrast agent and advanced infrared imaging, residual tumor cells are to be visualized and removed during surgery. If this is not possible, a second step involves the use of a molecularly targeted alpha-radiation therapy. The team has been awarded € 900,000 in program-oriented funding from the Helmholtz Association’s Impulse and Networking Fund for this research.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Präzisere Sarkomtherapie: Dresdner Forschungsteam entwickelt bildgestützte molekulare Therapie	2	7	16-07-2026
2	Brain tumor vaccine links mutation targeting to eight-year survival gains	7	8	06-07-2026
3	Впервые проведена терапия нейроэндокринного рака с помощью лютеция-177	0	0	21-05-2025
4	From the Lab to Those Affected: The Hector Institute for Translational Brain Research Enters Its Third Funding Period	5	7	16-07-2026
5	Neue Arbeitsgruppe am Kinderkrebs-Zentrum Hamburg: Den Energiequellen aggressiver Hirntumoren auf der Spur	2	7	16-07-2026
6	New experimental approach may help overcome drug resistance in deadly brain cancer	5	8	09-07-2026
7	Насколько близка победа над раком: новые методы лечения	0	0	22-08-2019
8	Precision therapy for metastatic prostate cancer improves survival	2	7	20-08-2024
9	Центр томотерапии для лечения онкозаболеваний начнет работать в Ульяновске до конца года	0	0	11-07-2019
10	New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer	5	7	02-07-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 5. Информативность: 7. Источник: idw-online.de.